Volume | 8,616,661 |
|
|||||
News | - | ||||||
Day High | 9.92 | Low High |
|||||
Day Low | 9.74 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Viatris Inc | VTRS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
9.77 | 9.74 | 9.92 | 9.83 | 9.76 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
30,056 | 8,616,661 | US$ 9.83 | US$ 84,714,530 | - | 8.74 - 12.3993 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:42:26 | 14 | US$ 9.89 | USD |
Viatris (VTRS) Options Flow Summary
Viatris Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
11.78B | 1.20B | - | 16.26B | 2.08B | 1.73 | 5.67 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Viatris News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VTRS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.15 | 9.92 | 9.10 | 9.63 | 9,122,480 | 0.68 | 7.43% |
1 Month | 9.10 | 9.92 | 8.95 | 9.38 | 7,986,552 | 0.73 | 8.02% |
3 Months | 9.76 | 10.37 | 8.74 | 9.44 | 8,951,369 | 0.07 | 0.72% |
6 Months | 9.70 | 11.48 | 8.74 | 9.92 | 8,791,661 | 0.13 | 1.34% |
1 Year | 10.90 | 12.3993 | 8.74 | 10.20 | 9,009,314 | -1.07 | -9.82% |
3 Years | 17.50 | 18.86 | 8.42 | 12.03 | 9,927,785 | -7.67 | -43.83% |
5 Years | 16.46 | 18.86 | 8.42 | 12.21 | 10,119,183 | -6.63 | -40.28% |
Viatris Description
We are Viatris. A new kind of global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines advance sustainable operations develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway. Formed in November 2020 we bring together scientific manufacturing and distribution expertise with proven regulatory medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. At Viatris our portfolio comprises more than 1400 approved molecules across a wide range of therapeutic areas spanning both non-communicable and infectious diseases including globally recognized brands complex generic and branded medicines and a growing portfolio of biosimilars. |